Table 1.
Demographic, clinical, and laboratory characteristics of the individuals included in the study.
| Overall (n = 177) | Negative for COVID-19 (n = 107) | Positive for COVID-19 (n = 70) | Value of p* | ||
|---|---|---|---|---|---|
| Median age (IQR) | 53 (36–67) | 56 (32.5–66.5) | 49.5 (39.3–66.8) | 0.8 | |
| Age [No. (%)] |
≥2–17 yo | 19 (10.7) | 16 (15.0) | 3 (4.3) | 0.03 |
| ≥18 yo | 158 (89.3) | 91 (85.0) | 67 (95.7) | ||
| Sex [No. (%)] |
Male | 95 (53.7) | 63 (58.9) | 38 (54.3) | 0.5 |
| Female | 82 (46.3) | 44 (41.1) | 32 (45.7) | ||
| Elevated C-reactive protein [No. (%)] |
Yes | 71 (40.1) | 43 (40.2) | 28 (40.0) | 1 |
| No | 9 (5.1) | 1 (0.9) | 8 (11.4) | ||
| Unknown | 97 (54.8) | 63 (58.9) | 34 (48.6) | ||
| Elevated procalcitonin [No. (%)] |
Yes | 27 (15.3) | 33 (30.8) | 4 (5.7) | 0.0001 |
| No | 113 (63.8) | 4 (3.7) | 23 (32.9) | ||
| Unknown | 37 (20.9) | 70 (65.4) | 43 (61.4) | ||
*
Chi-squared test, Fisher’s exact test, or Mann Whitney U test.
Data exclude 23 samples from adults donating blood for whom individual-level data were not available.